NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Research Council (US) Committee on Scientific Milestones for the Development of a Gene Sequence-Based Classification System for the Oversight of Select Agents. Sequence-Based Classification of Select Agents: A Brighter Line. Washington (DC): National Academies Press (US); 2010.

Cover of Sequence-Based Classification of Select Agents

Sequence-Based Classification of Select Agents: A Brighter Line.

Show details

References

  1. Abramovitch RB, Anderson JC, et al. Bacterial elicitation and evasion of plant innate immunity. Nat Rev Mol Cell Biol. 2006;7(8):601–611. [PMC free article: PMC2842591] [PubMed: 16936700]
  2. Afonnikov DA, Kolchanov NA. CRASP: a program for analysis of coordinated substitutions in multiple alignments of protein sequences. Nucl Acids Res. 2004;32(suppl_2):W64–68. [PMC free article: PMC441589] [PubMed: 15215352]
  3. Agarwal KL, Buchi H, et al. Total Synthesis of the Gene for an Alanine Transfer Ribonucleic Acid from Yeast. Nature. 1970;227(5253):27–34. [PubMed: 5422620]
  4. Agarwal R, Binz T, et al. Analysis of Active Site Residues of Botulinum Neurotoxin E by Mutational, Functional, and Structural Studies: Glu335Gln Is an Apoenzyme. Biochemistry. 2005;44(23):8291–8302. [PubMed: 15938619]
  5. Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nature Publishing Group; Nature Reviews Immunology. 2003;3:36. [PubMed: 12511874]
  6. Anandalakshmi R, Pruss GJ, et al. A viral suppressor of gene silencing in plants. Proceedings of the National Academy of Sciences of the United States of America. 1998;95(22):13079–13084. [PMC free article: PMC23715] [PubMed: 9789044]
  7. Ben-David M, Noivirt-Brik O, et al. Assessment of CASP8 structure predictions for template free targets. Proteins: Structure, Function, and Bioinformatics. 2009;77(S9):50–65. [PubMed: 19774550]
  8. Bent AF, Mackey D. Elicitors, Effectors, and R Genes: The New Paradigm and a Lifetime Supply of Questions. Annual Review of Phytopathology. 2007;45(1):399–436. [PubMed: 17506648]
  9. Berger KM, Pinard W, et al. Minimizing the Risks of Synthetic DNA: Scientists’ Views on the U.S. Government’s Guidance on Synthetic Genomics. 2009.
  10. Black DS, Bliska JB. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Molecular Microbiology. 2000;37(3):515–527. [PubMed: 10931345]
  11. Bowie AG, Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol. 2008;8(12):911–922. [PubMed: 18989317]
  12. Breeze, Budowle, et al., editors. Microbial Forensics. Elsevier; Academic Press; 2005.
  13. Brigneti G, Voinnet O, et al. Viral pathogenicity determinants are suppressors of trans-gene silencing in Nicotiana benthamiana. EMBO J. 1998;17(22):6739–6746. [PMC free article: PMC1171019] [PubMed: 9822616]
  14. Buller RM, Palumbo GJ. Poxvirus pathogenesis. Microbiol Mol Biol Rev. 1991;55(1):80–122. [PMC free article: PMC372802] [PubMed: 1851533]
  15. Casadevall A, Relman DA. Microbial threat lists: obstacles in the quest for bio-security? Nature Reviews Microbiology. 2010;8(2):149–154. [PubMed: 20065941]
  16. CDC. Classification of Etiologic Agents on the Basis of Hazard. U. S. N. C. D. Center; Atlanta, GA: 1974.
  17. CDC. Notification of Exclusion of Attenuated Strains. 2005.
  18. CDC/NIH. Biosafety in microbiological and biomedical laboratories. 2007. from http://purl​.access.gpo.gov/GPO/LPS121160.
  19. Cello J, Paul AV, et al. Chemical Synthesis of Poliovirus cDNA: Generation of Infectious Virus in the Absence of Natural Template. Science. 2002;297(5583):1016–1018. [PubMed: 12114528]
  20. Chang JH, Urbach JM, et al. A High-Throughput, Near-Saturating Screen for Type III Effector Genes from Pseudomonas syringae. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(7):2549–2554. [PMC free article: PMC549004] [PubMed: 15701698]
  21. Chang MCY, Eachus RA, et al. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol. 2007;3(5):274–277. [PubMed: 17438551]
  22. Commission on the Prevention of WMD Proliferation and Terrorism. World at Risk: the report of the Commission on the Prevention of WMD Proliferation and Terrorism. New York: Vintage Books; 2008.
  23. Couch BC, Fudal I, et al. Origins of Host-Specific Populations of the Blast Pathogen Magnaporthe oryzae in Crop Domestication With Subsequent Expansion of Pandemic Clones on Rice and Weeds of Rice. Genetics. 2005;170(2):613–630. [PMC free article: PMC1450392] [PubMed: 15802503]
  24. Damon IK. Genus Orthopoxvirus: Variola virus. Poxviruses. 2007:47–64.
  25. DHHS. Interstate shipment of etiologic agents; proposed rule. Federal Register. 1979;44(226):66853–5. [PubMed: 10244494]
  26. DHHS. 42 CFR Part 72: Additional Requirements for Facilities Transferring or Receiving Select Agents. Federal Register. 1996;61:55190–55200.
  27. DHHS. Public Health Security and Bioterrorism Preparedness and Response Act of 2002. 2002.
  28. DHHS. 42 CFR 72 and 73 and 42 CFR Part 1003: Possession, Use, and Transfer of Select Agents and Toxins. Final Rule, Federal Register. 2005;70:12294–13325.
  29. DHHS. Screening Framework Guidance for Synthetic Double-Stranded DNA Providers. Federal Register. 2009;74
  30. DHS. Bioterrorism Risk Assessment. Fort Detrick, MD: Biological Threat Characterization Center of the National Biodefense Analysis and Countermeasures Center; 2006.
  31. Dias MB, Reyes-Gonzalez L, et al. Effects of the USA PATRIOT ACT and the 2002 Bioterrorism Preparedness Act on select agent research in the United States. Proceedings of the National Academy of Sciences. 2010;107:9556–9561. [PMC free article: PMC2906869] [PubMed: 20457912]
  32. Doolittle R. Similar amino acid sequences: chance or common ancestry? Science. 1981;214(4517):149–159. [PubMed: 7280687]
  33. Dunoyer P, Lecellier C-H, et al. Probing the MicroRNA and Small Interfering RNA Pathways with Virus-Encoded Suppressors of RNA Silencing. Plant Cell. 2004;16(5):1235–1250. [PMC free article: PMC423212] [PubMed: 15084715]
  34. Dymond JS, Scheifele LZ, et al. Teaching Synthetic Biology, Bioinformatics and Engineering to Undergraduates: The Interdisciplinary Build-a-Genome Course. Genetics. 2009;181(1):13–21. [PMC free article: PMC2621162] [PubMed: 19015540]
  35. Esposito JJ, Sammons SA, et al. Genome Sequence Diversity and Clues to the Evolution of Variola (Smallpox) Virus. Science. 2006:1125134. [PubMed: 16873609]
  36. Fallman M, Andersson K, et al. Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells. Infection and Immunity. 1995;63(8):3117–3124. [PMC free article: PMC173425] [PubMed: 7622239]
  37. Fishman JA. Infection in Solid-Organ Transplant Recipients. N Engl J Med. 2007;357(25):2601–2614. [PubMed: 18094380]
  38. Flannagan RS, Cosio G, et al. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Micro. 2009;7(5):355–366. [PubMed: 19369951]
  39. Fleishman SJ, Yifrach O, et al. An evolutionarily conserved network of amino acids mediates gating in voltage-dependent potassium channels. Journal of Molecular Biology. 2004;340(2):307–318. [PubMed: 15201054]
  40. Frankel A, Welsh P, et al. Role of arginine 180 and glutamic acid 177 of ricin toxin A chain in enzymatic inactivation of ribosomes. Mol Cell Biol. 1990;10(12):6257–6263. [PMC free article: PMC362900] [PubMed: 1978925]
  41. Fujii N, Kimura K, et al. A zinc-protease specific domain in botulinum and tetanus neurotoxins. Toxicon. 1992;30(11):1486–1488. [PubMed: 1485344]
  42. Genomesonline. GOLD: Genomes OnLine Databases. 2009. from http://www​.genomesonline.org/gold.cgi/
  43. Gibson DG, Glass JI, et al. Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome. Science. 2010;329(5987):52–56. [PubMed: 20488990]
  44. Gillespie JJ, Ammerman NC, et al. Louse- and flea-borne rickettsioses: biological and genomic analyses. Vet Res. 2009;40(2) [PMC free article: PMC2695025] [PubMed: 19036234]
  45. Graff JW, Ettayebi K, et al. Rotavirus NSP1 Inhibits NFΰB Activation by Inducing Proteasome-Dependent Degradation of Î2-TrCP: A Novel Mechanism of IFN Antagonism. PLoS Pathog. 2009;5(1):e1000280. [PMC free article: PMC2627925] [PubMed: 19180189]
  46. Gubser C, Hue S, et al. Poxvirus genomes: a phylogenetic analysis. J Gen Virol. 2004;85(1):105–117. [PubMed: 14718625]
  47. Haber E, Anfinsen CB. Side-chain Interactions Governing the Pairing of Half-cystine Residues in Ribonuclease. Journal of Biological Chemistry. 1962;237(6):1839–1844. [PubMed: 13903380]
  48. Hannenhalli SS, Russell RB. Analysis and prediction of functional sub-types from protein sequence alignments. Journal of Molecular Biology. 2000;303(1):61–76. [PubMed: 11021970]
  49. He Y, Yeh DC, et al. Solution NMR Structures of IgG Binding Domains with Artificially Evolved High Levels of Sequence Identity but Different Folds. Biochemistry. 2005;44(43):14055–14061. [PubMed: 16245921]
  50. Hussain S, Perlman S, et al. Severe Acute Respiratory Syndrome Coronavirus Protein 6 Accelerates Murine Hepatitis Virus Infections by More than One Mechanism. J Virol. 2008;82(14):7212–7222. [PMC free article: PMC2446958] [PubMed: 18448520]
  51. Iyer LM, Balaji S, et al. Evolutionary genomics of nucleocytoplasmic large DNA viruses. Virus Research. 2006;117(1):156–184. [PubMed: 16494962]
  52. Janin J. Assessing predictions of protein-protein interaction: The CAPRI experiment. Protein Science. 2005;14(2):278–283. [PMC free article: PMC2253420] [PubMed: 15659362]
  53. Joiner K, Brown E, et al. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing. J Immunol. 1983;130(2):845–849. [PubMed: 6848598]
  54. Keedy DA, Williams CJ, et al. The other 90% of the protein: Assessment beyond the Calphas for CASP8 template-based and high-accuracy models. Proteins: Structure, Function, and Bioinformatics. 2009;77(S9):29–49. [PMC free article: PMC2877634] [PubMed: 19731372]
  55. Kim DW, Lenzen G, et al. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(39):14046–14051. [PMC free article: PMC1236552] [PubMed: 16162672]
  56. Kim Y, Misna D, et al. Structure of a ricin mutant showing rescue of activity by a non-catalytic residue. Biochemistry. 1992;31(12):3294–3296. [PubMed: 1348187]
  57. Kingsley RA, Bäumler AJ. Host adaptation and the emergence of infectious disease: the Salmonella paradigm. Molecular Microbiology. 2000;36(5):1006–1014. [PubMed: 10844686]
  58. Konkel ME, Tilly K. Temperature-regulated expression of bacterial virulence genes. Microbes and Infection. 2000;2(2):157–166. [PubMed: 10742688]
  59. Kortepeter MG, Parker GW. Potential biological weapons threats. Emerging infectious diseases. 1999;5(4) [PMC free article: PMC2627749] [PubMed: 10458957]
  60. Kuhlman B, Dantas G, et al. Design of a Novel Globular Protein Fold with Atomic-Level Accuracy. Science. 2003;302(5649):1364–1368. [PubMed: 14631033]
  61. Kwok R. Five hard truths for synthetic biology. Nature. 2010;463(7279):288. [PubMed: 20090726]
  62. Lacy DB, Tepp W, et al. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol. 1998;5(10):898–902. [PubMed: 9783750]
  63. Lambris JD, Ricklin D, et al. Complement evasion by human pathogens. Nat Rev Micro. 2008;6(2):132–142. [PMC free article: PMC2814840] [PubMed: 18197169]
  64. Lartigue C, Vashee S, et al. Creating Bacterial Strains from Genomes That Have Been Cloned and Engineered in Yeast. Science. 2009;325(5948):1693–1696. [PubMed: 19696314]
  65. Lee SK, Chou H, et al. Metabolic engineering of microorganisms for biofuels production: from bugs to synthetic biology to fuels. Current Opinion in Biotechnology. 2008;19(6):556–563. [PubMed: 18996194]
  66. Lefkowitz EJ, Wang C, et al. Poxviruses: past, present and future. Virus Research. 2006;117(1):105–118. [PubMed: 16503070]
  67. Li Y, Carroll DS, et al. On the origin of smallpox: Correlating variola phylogenics with historical smallpox records. Proceedings of the National Academy of Sciences. 2007;104(40):15787–15792. [PMC free article: PMC2000395] [PubMed: 17901212]
  68. Lindesmith L, Moe C, et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med. 2003;9(5):548–553. [PubMed: 12692541]
  69. López G, Ezkurdia I, et al. Assessment of ligand binding residue predictions in CASP8. Proteins: Structure, Function, and Bioinformatics. 2009;77(S9):138–146. [PMC free article: PMC3204792] [PubMed: 19714771]
  70. Lu R, Folimonov A, et al. Three distinct suppressors of RNA silencing encoded by a 20-kb viral RNA genome. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(44):15742–15747. [PMC free article: PMC524217] [PubMed: 15505219]
  71. Matson JS, Withey JH, et al. Regulatory Networks Controlling Vibrio cholerae Virulence Gene Expression. Infect Immun. 2007;75(12):5542–5549. [PMC free article: PMC2168339] [PubMed: 17875629]
  72. Maurelli AT, Fernandez RE, et al. ”Black holes” and bacterial pathogenicity: A large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America. 1998;95(7):3943–3948. [PMC free article: PMC19942] [PubMed: 9520472]
  73. Maurer SM, Fischer M, et al. Making Commercial Biology Safer: What the Gene Synthesis Industry Has Learned About Screening Customers and Orders. 2009.
  74. McAuley JL, Zhang K, et al. The Effects of Influenza A Virus PB1-F2 Protein on Polymerase Activity Are Strain Specific and Do Not Impact Pathogenesis. J Virol. 84(1):558–564. [PMC free article: PMC2798424] [PubMed: 19828614]
  75. McLeod SM, Kimsey HH, et al. CTXϕ; and Vibrio cholerae: exploring a newly recognized type of phage-host cell relationship. Molecular Microbiology. 2005;57(2):347–356. [PubMed: 15978069]
  76. Mohamed MR, Rahman MM, et al. Proteomic screening of variola virus reveals a unique NF-ΰB inhibitor that is highly conserved among pathogenic orthopoxviruses. Proceedings of the National Academy of Sciences. 2009;106(22):9045–9050. [PMC free article: PMC2683884] [PubMed: 19451633]
  77. Moss B. Poxviridae: The viruses and their replication Fields Viology. Knipe DM, Howley PM, editors. Lippincott, William and Wilkins; 2007. pp. 2905–2946.
  78. Moult J. A decade of CASP: progress, bottlenecks and prognosis in protein structure prediction. Current Opinion in Structural Biology. 2005;15(3):285–289. [PubMed: 15939584]
  79. Moulton EA, Atkinson JP, et al. Surviving Mousepox Infection Requires the Complement System. PLoS Pathog. 2008;4(12):e1000249. [PMC free article: PMC2597719] [PubMed: 19112490]
  80. Munishkin A, Wool IG. Systematic Deletion Analysis of Ricin A-Chain Function. Journal of Biological Chemistry. 1995;270(51):30581–30587. [PubMed: 8530493]
  81. NBACC. National Biodefense Analysis & Countermeasures Center Strategic Plan. NBACC; 2009.
  82. Neish A. Bacterial inhibition of eukaryotic pro-inflammatory pathways. Immunologic Research. 2004;29(1):175–185. [PubMed: 15181280]
  83. NIH. Guidelines for research involving recombinant DNA molecules: NIH guidelines. U.S. Dept. of Health, Education, and Welfare, Public Health Service; 1976.
  84. NRC. Biotechnology research in an age of terrorism. Washington, D.C: National Academies Press; 2004.
  85. NRC. Department of Homeland Security bioterrorism risk assessment: a call for change. Washington, D C: National Academies Press; 2008.
  86. NRC. Live Variola virus: Considerations for Continuing Research. Washington, DC: National Academies Press; 2009a.
  87. NRC. Responsible Research with Biological Select Agents and Toxins. Washington, DC: National Academies Press; 2009b.
  88. NRC. A survey of attitudes and actions on dual use research in the life sciences: a collaborative effort of the National Research Council and the American Association for the Advancement of Science. Washington, D.C: National Academies Press; 2009c.
  89. NSABB. Addressing Biosecurity Concerns Related to the Synthesis of Select Agents. 2006.
  90. NSABB. Enhancing Personnel Reliability among Individuals with Access to Select Agents. 2009a.
  91. NSABB. Report of the Working Group on Strengthening the Biosecurity of the United States. 2009b.
  92. NSC. National strategy for countering biological threats. Washington, D.C: National Security Council; 2009.
  93. Odom MR, Curtis Hendrickson R, et al. Poxvirus protein evolution: Family wide assessment of possible horizontal gene transfer events. Virus Research. 2009;144(1–2):233–249. [PMC free article: PMC2779260] [PubMed: 19464330]
  94. OECD (Organisation for Economic Co-operation and Development) OECD Best Practice Guidelines on Biosecurity for BRCs (Biological Resource Centers) Paris: OECD; 2007. Available at, http://www​.oecd.org/dataoecd​/6/27/38778261.pdf.
  95. Park IH, Pritchard DG, et al. Discovery of a New Capsular Serotype (6C) within Serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol. 2007;45(4):1225–1233. [PMC free article: PMC1865839] [PubMed: 17267625]
  96. Paya CV. Fungal Infections in Solid-Organ Transplantation. Clinical Infectious Diseases. 1993;16 (5):677–688. [PubMed: 8507760]
  97. Pesenti PT. DHS S&T Bioterrorism Risk Assessment (BTRA) 2009.
  98. Preston R. Annals of Warfare: The Bioweaponeers. The New Yorker. 1998:52–65.
  99. Qian B, Raman S, et al. High-resolution structure prediction and the crystallographic phase problem. Nature. 2007;450(7167):259–264. [PMC free article: PMC2504711] [PubMed: 17934447]
  100. Qiu W, Park J-W, et al. Tombusvirus P19-Mediated Suppression of Virus-Induced Gene Silencing Is Controlled by Genetic and Dosage Features That Influence Pathogenicity. Molecular Plant-Microbe Interactions. 2007;15(3):269–280. [PubMed: 11952130]
  101. Raman S, Vernon R, et al. Structure prediction for CASP8 with all-atom refinement using Rosetta. Proteins: Structure, Function, and Bioinformatics. 2009;77(S9):89–99. [PMC free article: PMC3688471] [PubMed: 19701941]
  102. Read TD, Peterson SN, et al. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature. 2003;423(6935):81–86. [PubMed: 12721629]
  103. Rotz LD, Khan AS, et al. Public health assessment of potential biological terrorism agents. Emerging infectious diseases. 2002;8(2):225–30. [PMC free article: PMC2732458] [PubMed: 11897082]
  104. Schnoes AM, Brown SD, et al. Annotation Error in Public Databases: Misannotation of Molecular Function in Enzyme Superfamilies. PLoS Comput Biol. 2009;5(12):e1000605. [PMC free article: PMC2781113] [PubMed: 20011109]
  105. Schorey JS, Carroll MC, et al. A Macrophage Invasion Mechanism of Pathogenic Mycobacteria. Science. 1997;277(5329):1091–1093. [PubMed: 9262476]
  106. Schwan TG, Piesman J. Vector Interactions and Molecular Adaptations of Lyme Disease and Relapsing Fever Spirochetes Associated with Transmission by Ticks. Emerg Infect Dis. 2002;8(2):115–21. [PMC free article: PMC2732444] [PubMed: 11897061]
  107. Sing A, Reithmeier-Rost D, et al. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(44):16049–16054. [PMC free article: PMC1276055] [PubMed: 16239347]
  108. Sodhi A, Montaner S, et al. Viral hijacking of G-protein-coupled-receptor signalling networks. Nat Rev Mol Cell Biol. 2004;5(12):998–1012. [PubMed: 15573137]
  109. Soosaar JLM, Burch-Smith TM, et al. Mechanisms of plant resistance to viruses. Nat Rev Micro. 2005;3(10):789–798. [PubMed: 16132037]
  110. Stukenbrock EH, Banke S, et al. Origin and Domestication of the Fungal Wheat Pathogen Mycosphaerella graminicola via Sympatric Speciation. Mol Biol Evol. 2007;24(2):398–411. [PubMed: 17095534]
  111. Stukenbrock EH, McDonald BA. The Origins of Plant Pathogens in Agro-Ecosystems. Annual Review of Phytopathology. 2008;46(1):75–100. [PubMed: 18680424]
  112. Sumby P, Zhang S, et al. A Chemokine-Degrading Extracellular Protease Made by Group A Streptococcus Alters Pathogenesis by Enhancing Evasion of the Innate Immune Response. Infect. Immun. 2008:IAI.01354-07. [PMC free article: PMC2258835] [PubMed: 18174342]
  113. Sutton V. Survey Finds Biodefense Researcher Anxiety - Over Inadvertently Violating Regulations. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. 2009;7(2) [PMC free article: PMC2995343] [PubMed: 19635007]
  114. The White House. HSPD-10: Biodefense in the 21st Century. 2004.
  115. Tscharke DC, Reading PC, et al. Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J Gen Virol. 2002;83(8):1977–1986. [PubMed: 12124461]
  116. Tucker J. Preventing the Misuse of Pathogens: The Need for Global Biosecurity. Arms Control Today. 2003;33
  117. Upton C, Slack S, et al. Poxvirus Orthologous Clusters: toward Defining the Minimum Essential Poxvirus Genome. J Virol. 2003;77(13):7590–7600. [PMC free article: PMC164831] [PubMed: 12805459]
  118. van der Does HC, Rep M. Virulence Genes and the Evolution of Host Specificity in Plant-Pathogenic Fungi. Molecular Plant-Microbe Interactions. 2007;20(10):1175–1182. [PubMed: 17918619]
  119. Vivian A, Gibbon MJ. Avirulence genes in plant-pathogenic bacteria: signals or weapons? Microbiology. 1997;143(3):693–704.
  120. Voinnet O, Lederer C, et al. A Viral Movement Protein Prevents Spread of the Gene Silencing Signal in Nicotiana benthamiana. Cell. 2000;103(1):157–167. [PubMed: 11051555]
  121. Walport MJ. Complement- First of Two Parts. N Engl J Med. 2001a;344(14):1058–1066. [PubMed: 11287977]
  122. Walport MJ. Complement- Second of Two Parts. N Engl J Med. 2001b;344(15):1140–1144. [PubMed: 11297706]
  123. WHO (World Health Organization) Laboratory Biosafety Manual. 3rd ed. Geneva: WHO; 2004. WHO/CDS/CSR/LYO/2004.11. Available at http://www​.who.int/csr/resources​.publications​/biosafety/WHO_CDS_CSR_LYO_2004_11​/en/
  124. Working Group on Strengthening the Biosecurity of the United States. Report of the Working Group on Strengthening the Biosecurity of the United States. 2009.
  125. Wu K, Li W, et al. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor. Proceedings of the National Academy of Sciences. 2009;106(47):19970–19974. [PMC free article: PMC2785276] [PubMed: 19901337]
  126. Yoshida N, Oeda K, et al. Protein function: Chaperonin turned insect toxin. Nature. 2001;411(6833):44–44. [PubMed: 11333970]
  127. Zhang J, Wang Q, et al. MUFOLD: A new solution for protein 3D structure prediction. Proteins: Structure, Function, and Bioinformatics. 78(5):1137–1152. [PMC free article: PMC2885889] [PubMed: 19927325]
  128. Zychlinsky A, Kenny B, et al. IpaB mediates macrophage apoptosis induced by Shigella flexneri. Molecular Microbiology. 1994;11(4):619–627. [PubMed: 8196540]
Copyright © 2010, National Academy of Sciences.
Bookshelf ID: NBK50864
PubReader format: click here to try

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (3.0M)

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to pubmed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...